Histological changes and risk factor associations in type 2 atherosclerotic lesions (fatty streaks) in young adults

Atherosclerosis

Volumn 219, Issue 1, 2011, Pages 184-190

  Homma, Satoki ^a   Troxclair, Dana A ^a   Zieske, Arthur W ^a   Malcom, Gray T ^a   Strong, Jack P ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aorta; Coronary heart disease; Fatty streaks; Histomorphometry; Immunohistochemistry; Risk factors; Smooth muscle foam cells

Indexed keywords

COLLAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AORTA ATHEROSCLEROSIS; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; FOAM CELL; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; THORACIC AORTA;

ADOLESCENT; ADULT; AORTA, THORACIC; ATHEROSCLEROSIS; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; FOAM CELLS; HUMANS; MALE; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS;

EID: 80054989841     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.07.022     Document Type: Article

References (32)

1. Katz S.S., Shipley G.G., Small D.M. Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. J Clin Invest 1976, 58:200-201.
2. Small D.M., Bond M.G., Waugh D., Prack M., Sawyer J.K. Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. J Clin Invest 1984, 73:1590-1605.
3. Strong J.P., Malcom G.T., McMahan C.A., et al. Prevalence and extent of atherosclerosis in adolescents and young adults. Implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 1999, 281:727-735.
4. Homma S., Ishii T., Tsugane S., Hirose N. Different effects of hypertension and hypercholesterolemia on the natural history of aortic atherosclerosis by the stage of intimal lesions. Atherosclerosis 1997, 128:85-95.
5. Homma S., Ishii T., Malcom G.T., et al. Histopathological modifications of early atherosclerotic lesions by risk factors-findings in PDAY subjects. Atherosclerosis 2001, 156:389-399.
6. Wissler R.W. USA multicenter study of the pathobiology of atherosclerosis in youth. Ann N Y Acad Sci 1991, 623:26-39.
7. Homma S, Troxclair DA, Zieske AW, Malcom GT, Strong JP, for the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group. Histological topographical comparisons of atherosclerosis progression in juveniles and young adults. Atherosclerosis 2008; 197:791-8.
8. McGill H.C., Strong J.P., Tracy R.E., McMahan C.A., Oalmann M.C. Relation of a postmortem renal index of hypertension to atherosclerosis in youth. Arterioscler Thromb Vasc Biol 1995, 15:2222-2228.
9. McGill H.C., McMahan C.A., Malcom G.T., Oalmann M.C., Strong J.P. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Arterioscler Thromb Vasc Biol 1995, 15:431-440.
10. McGill H.C., McMahan C.A., Malcom G.T., Oalmann M.C., Strong J.P. Effect of serum lipoprotein and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological determinants of atherosclerosis in youth. Arterioscler Thromb Vasc Biol 1997, 17:95-106.
11. Tracy R.E., Durban M.V., Heigle T., Oalmann M.C. Two variants of nephrosclerosis separately related to age and blood pressure. Am J Pathol 1988, 131:270-282.
12. Stary H.C., Chandler B., Glagov S., et al. A definition of the intima of the initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on atherosclerosis. American Heart Association. Arterioscler Thromb 1994, 14:840-856.
13. Stary H.C., Chandler B., Dinsmore R.E., et al. A definition of the intima of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the council on atherosclerosis. American Heart Association. Circulation 1995, 92:1355-1374.
14. Taajes D.J., Wadsworth M.P., Schneider D.J., Sobel B.E. Improved quantitative characterization of atherosclerotic plaque composition with immunohistochemistry, confocal fluorescence microscopy, and computer-assisted image analysis. Histochem Cell Biol 2000, 113:161-173.
15. Solberg L.A., Strong J.P. Risk factors and atherosclerotic lesions. A review of autopsy studies. Arteriosclerosis 1983, 3:187-198.
16. Majesky M.W. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 2007, 27:1248-1258.
17. Malcom G.T., McMahan C.A., McGill H.C., et al. Associations of arterial tissue lipids with coronary heart disease risk factors in young people. Atherosclerosis 2009, 203:515-521.
18. Shao B., Oda M.N., Oram J.F., Heinecke J.W. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Curr Opin Cardiol 2006, 21:322-328.
19. Nakashima Y., Fujii H., Sumiyoshi S., Wight T.N., Sueishi K. Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol 2007, 27:1159-1165.
20. Doran A.C., Meller N., McNamara C.A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28:812-819.
21. Stary H.C. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989, 9:119-132.
22. Homma S., Hirose N., Ishida H., Ishii T., Araki G. Carotid plaque and intima-media thickness assessed by B-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke 2001, 32:830-835.
23. Korshunov V.A., Berk B.C. Smooth muscle apoptosis and vascular remodeling. Curr Opin Hematol 2008, 15:250-254.
24. Assmann G., Gotto A.M. HDL cholesterol and protective factors in atherosclerosis. Circulation 2004, 109:III8-III14.
25. Tall A.R., Yvan-Charvet L., Terasaka N., Pagler T., Wang N. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab 2008, 7:365-375.
26. Barter P.J., Nicholls S., Rye K.A., et al. Anti-inflammatory properties of HDL. Circ Res 2004, 95:764-772.
27. Luechtenborg B., Hofnagel O., Weissen-Plenz G., Severs N.J., Robenek H. Function of scavenger receptor class A type I/II is not important for smooth muscle foam cell formation. Eur J Cell Biol 2008, 87:91-99.
28. Li H., Freeman M.W., Libby P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 1995, 95:122-133.
29. Zieske A.W., Tracy R.P., McMahan C.A., et al. Elevated serum C-reactive protein levels and advanced atherosclerosis in youth. Arterioscler Thromb Vasc Biol 2005, 25:1237-1243. For the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group.
30. Frontini M.J., O'Neil C., Sawyez C., et al. Lipid incorporation inhibits Src-dependent assembly of fibronectin and type I collagen by vascular smooth muscle cells. Circ Res 2009, 104:832-841.
31. Marx N., Walcher D., Raichle C., et al. C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Biol 2004, 24:540-545.
32. Yang S.N.Y., Burch M.L., Tannock L.R., et al. Transforming growth factor-β regulation of proteoglycan synthesis in vascular smooth muscle: contribution to lipid binding and accelerated atherosclerosis in diabetes. J Diabetes 2010, 2:233-242.